X4 Pharmaceuticals Inc (NASDAQ: XFOR) on Monday, plunged -4.00% from the previous trading day, before settling in for the closing price of $0.31. Within the past 52 weeks, XFOR’s price has moved between $0.26 and $1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -25.00% over the last five years. The company achieved an average annual earnings per share of 73.68%. With a float of $115.02 million, this company’s outstanding shares have now reached $168.51 million.
The firm has a total of 93 workers. Let’s measure their productivity. In terms of profitability, gross margin is 85.2%, operating margin of -618.81%, and the pretax margin is -398.61%.
X4 Pharmaceuticals Inc (XFOR) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of X4 Pharmaceuticals Inc is 33.77%, while institutional ownership is 30.34%. The most recent insider transaction that took place on May 17 ’24, was worth 14,654. In this transaction Chief Commercial Officer of this company bought 21,646 shares at a rate of $0.68, taking the stock ownership to the 115,769 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Commercial Officer bought 13,404 for $0.34, making the entire transaction worth $4,598. This insider now owns 129,173 shares in total.
X4 Pharmaceuticals Inc (XFOR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.21% during the next five years compared to 73.95% growth over the previous five years of trading.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
X4 Pharmaceuticals Inc (XFOR) is currently performing well based on its current performance indicators. A quick ratio of 4.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 45.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
Analysing the last 5-days average volume posted by the [X4 Pharmaceuticals Inc, XFOR], we can find that recorded value of 1.45 million was lower than the volume posted last year of 3.71 million. As of the previous 9 days, the stock’s Stochastic %D was 21.95%. Additionally, its Average True Range was 0.04.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 5.34%, which indicates a significant decrease from 8.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.66% in the past 14 days, which was lower than the 201.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4538, while its 200-day Moving Average is $0.6066. Now, the first resistance to watch is $0.3064. This is followed by the second major resistance level at $0.3179. The third major resistance level sits at $0.3257. If the price goes on to break the first support level at $0.2871, it is likely to go to the next support level at $0.2793. Should the price break the second support level, the third support level stands at $0.2678.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
Market capitalization of the company is 51.23 million based on 173,662K outstanding shares. Right now, sales total 0 K and income totals -101,170 K. The company made 560 K in profit during its latest quarter, and -36,700 K in sales during its previous quarter.
